Thermo Fisher Scientific today announced the introduction of the Gibco CTS DynaXS single-use bioreactor for cell therapy manufacturing. Waltham, Massachusetts–based Thermo Fisher designed the expansion platform to help cell therapy developers scale manufacturing with control, flexibility and regulatory readiness. Thermo Fisher said its stirred-tank, single-use system supports cell expansion across development and early clinical volumes.…
Thermo Fisher, SHL Medical collab on drug delivery device production
Thermo Fisher Scientific today announced a strategic collaboration with drug delivery system provider SHL Medical. The collaboration coincides with the expansion of sterile fill-finish and auto-injector final assembly capacity at its Ridgefield, New Jersey site. Together, Thermo Fisher says its investments establish a fully integrated U.S.-based offering across sterile manufacturing, device assembly and commercial packaging…
Thermo Fisher expands investment in Asia bioprocessing for biopharma production
Thermo Fisher Scientific announced that it expanded its bioprocessing capabilities across Asia. The Waltham, Massachusetts-based company says the expansion reinforces its commitment to supporting the region’s growing biopharmaceutical industry. It plans to introduce a new Bioprocess Design Center in Hyderabad, India, in addition to expansions in existing Bioprocess Design Centers in Incheon, Korea, and Singapore.…
Thermo Fisher to invest $2B on U.S. manufacturing
Thermo Fisher Scientific announced today that it plans to invest an additional $2 billion in the U.S. over the next four years. The company said its investment should strengthen American innovation, manufacturing and economic competitiveness in the life sciences sector. It also comes as a number of companies consider investing in U.S. infrastructure amid potential…
Thermo Fisher opens new ultra-cold facility in Europe
Thermo Fisher Scientific announced that it opened a new clinical and commercial ultra-cold facility in the Netherlands. The company aims to expand its clinical trial network in Europe and accelerate the development of advanced therapies. Its new current good manufacturing practice (cGMP) facility in Bleiswijk offers pharmaceutical and biopharma customers tailored, end-to-end support throughout the…
Thermo Fisher Scientific launches cell therapy manufacturing tech
Thermo Fisher Scientific (NYSE:TMO) announced today that it unveiled the Gibco CTS DynaCellect magnetic separation system. Waltham, Massachusetts-based Thermo Fisher designed DynaCellect to help cell therapy developers easily move from process and clinical development to commercial manufacturing. The next-generation instrument features cell isolation, activation and depletion along with Dynabeads magnetic beads removal. Thermo Fisher said…
Thermo Fisher launches refrigerated vacuum concentrator
Thermo Fisher (NYSE: TMO) is debuting a SpeedVac refrigerated vacuum concentrator to maintain the temperature of heat-sensitive samples, including proteins. The SpeedVac SRF110 modular refrigerated vacuum concentrator offers programmability to allow operators to specify chamber temperature before and after a sample run. The system is available in a modular configuration known as SRF110P1 or in…